Cargando…

Robust radiosensitization of hemoglobin-curcumin nanoparticles suppresses hypoxic hepatocellular carcinoma

BACKGROUND: Radioresistance inducing by hypoxic microenvironment of hepatocellular carcinoma is a major obstacle to clinical radiotherapy. Advanced nanomedicine provides an alternative to alleviate the hypoxia extent of solid tumor, even to achieve effective synergistic treatment when combined with...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Ruoling, Gu, Yuan, Yang, Ying, He, Yuping, Huang, Wenpeng, Sun, Ting, Tang, Zaixiang, Wang, Yong, Yang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898525/
https://www.ncbi.nlm.nih.gov/pubmed/35248069
http://dx.doi.org/10.1186/s12951-022-01316-w
_version_ 1784663671435165696
author Gao, Ruoling
Gu, Yuan
Yang, Ying
He, Yuping
Huang, Wenpeng
Sun, Ting
Tang, Zaixiang
Wang, Yong
Yang, Wei
author_facet Gao, Ruoling
Gu, Yuan
Yang, Ying
He, Yuping
Huang, Wenpeng
Sun, Ting
Tang, Zaixiang
Wang, Yong
Yang, Wei
author_sort Gao, Ruoling
collection PubMed
description BACKGROUND: Radioresistance inducing by hypoxic microenvironment of hepatocellular carcinoma is a major obstacle to clinical radiotherapy. Advanced nanomedicine provides an alternative to alleviate the hypoxia extent of solid tumor, even to achieve effective synergistic treatment when combined with chemotherapy or radiotherapy. RESULTS: Herein, we developed a self-assembled nanoparticle based on hemoglobin and curcumin for photoacoustic imaging and radiotherapy of hypoxic hepatocellular carcinoma. The fabricated nanoparticles inhibited hepatoma migration and vascular mimics, and enhanced the radiosensitivity of hypoxic hepatoma cells in vitro via repressing cell proliferation and DNA damage repair, as well as inducing apoptosis. Benefit from oxygen-carrying hemoglobin combined with polyphenolic curcumin, the nanoparticles also effectively enhanced the photoacoustic contrast and the efficacy of radiotherapy for hepatocellular carcinoma in vivo. CONCLUSIONS: Together, the current study offered a radiosensitization platform for optimizing the efficacy of nanomedicines on hypoxic radioresistant tumor. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-022-01316-w.
format Online
Article
Text
id pubmed-8898525
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88985252022-03-17 Robust radiosensitization of hemoglobin-curcumin nanoparticles suppresses hypoxic hepatocellular carcinoma Gao, Ruoling Gu, Yuan Yang, Ying He, Yuping Huang, Wenpeng Sun, Ting Tang, Zaixiang Wang, Yong Yang, Wei J Nanobiotechnology Research BACKGROUND: Radioresistance inducing by hypoxic microenvironment of hepatocellular carcinoma is a major obstacle to clinical radiotherapy. Advanced nanomedicine provides an alternative to alleviate the hypoxia extent of solid tumor, even to achieve effective synergistic treatment when combined with chemotherapy or radiotherapy. RESULTS: Herein, we developed a self-assembled nanoparticle based on hemoglobin and curcumin for photoacoustic imaging and radiotherapy of hypoxic hepatocellular carcinoma. The fabricated nanoparticles inhibited hepatoma migration and vascular mimics, and enhanced the radiosensitivity of hypoxic hepatoma cells in vitro via repressing cell proliferation and DNA damage repair, as well as inducing apoptosis. Benefit from oxygen-carrying hemoglobin combined with polyphenolic curcumin, the nanoparticles also effectively enhanced the photoacoustic contrast and the efficacy of radiotherapy for hepatocellular carcinoma in vivo. CONCLUSIONS: Together, the current study offered a radiosensitization platform for optimizing the efficacy of nanomedicines on hypoxic radioresistant tumor. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-022-01316-w. BioMed Central 2022-03-05 /pmc/articles/PMC8898525/ /pubmed/35248069 http://dx.doi.org/10.1186/s12951-022-01316-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Gao, Ruoling
Gu, Yuan
Yang, Ying
He, Yuping
Huang, Wenpeng
Sun, Ting
Tang, Zaixiang
Wang, Yong
Yang, Wei
Robust radiosensitization of hemoglobin-curcumin nanoparticles suppresses hypoxic hepatocellular carcinoma
title Robust radiosensitization of hemoglobin-curcumin nanoparticles suppresses hypoxic hepatocellular carcinoma
title_full Robust radiosensitization of hemoglobin-curcumin nanoparticles suppresses hypoxic hepatocellular carcinoma
title_fullStr Robust radiosensitization of hemoglobin-curcumin nanoparticles suppresses hypoxic hepatocellular carcinoma
title_full_unstemmed Robust radiosensitization of hemoglobin-curcumin nanoparticles suppresses hypoxic hepatocellular carcinoma
title_short Robust radiosensitization of hemoglobin-curcumin nanoparticles suppresses hypoxic hepatocellular carcinoma
title_sort robust radiosensitization of hemoglobin-curcumin nanoparticles suppresses hypoxic hepatocellular carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898525/
https://www.ncbi.nlm.nih.gov/pubmed/35248069
http://dx.doi.org/10.1186/s12951-022-01316-w
work_keys_str_mv AT gaoruoling robustradiosensitizationofhemoglobincurcuminnanoparticlessuppresseshypoxichepatocellularcarcinoma
AT guyuan robustradiosensitizationofhemoglobincurcuminnanoparticlessuppresseshypoxichepatocellularcarcinoma
AT yangying robustradiosensitizationofhemoglobincurcuminnanoparticlessuppresseshypoxichepatocellularcarcinoma
AT heyuping robustradiosensitizationofhemoglobincurcuminnanoparticlessuppresseshypoxichepatocellularcarcinoma
AT huangwenpeng robustradiosensitizationofhemoglobincurcuminnanoparticlessuppresseshypoxichepatocellularcarcinoma
AT sunting robustradiosensitizationofhemoglobincurcuminnanoparticlessuppresseshypoxichepatocellularcarcinoma
AT tangzaixiang robustradiosensitizationofhemoglobincurcuminnanoparticlessuppresseshypoxichepatocellularcarcinoma
AT wangyong robustradiosensitizationofhemoglobincurcuminnanoparticlessuppresseshypoxichepatocellularcarcinoma
AT yangwei robustradiosensitizationofhemoglobincurcuminnanoparticlessuppresseshypoxichepatocellularcarcinoma